Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma
✍ Scribed by Woon-Puay Koh; Jian-Min Yuan; Renwei Wang; Sugantha Govindarajan; Rowena Oppenheimer; Zhen Quan Zhang; Mimi C. Yu; Sue Ann Ingles
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 178 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background and Objectives Hepatocellular carcinoma (HCC) is one of the most frequent malignant neoplasms worldwide, and is the second leading cause of cancer death in Taiwan. E‐cadherin is an epithelial cell adhesion molecule, and decreased E‐cadherin expression in HCC is associated
sis. Also, the activity of fetal P3 and P4 promoters was Increased prevalence of hepatitis C virus (HCV) infechigher in the nontumorous than in the tumorous area tion has been found in patients with hepatocellular carof the liver of HCC patients. The expression of IGF-II cinoma (HCC). The expression
## Abstract ## BACKGROUND. The secreted frizzled‐related protein 1 gene (__SFRP1__) encodes a Wnt/β‐catenin signaling antagonist and frequently is inactivated by promoter methylation in many tumors. However, the role of __SFRP1__ in hepatocellular carcinoma (HCC) is not clear. Therefore, the autho